Location
Global
Company size
83500
Industry
Target
AstraZeneca commits to reduce absolute scope 1 and 2 GHG emissions 98% by FY2026 from a FY2015 base year, and to reduce absolute scope 3 GHG emissions 50% by FY2030 from a FY2019 base year.
AstraZeneca PLC is a multinational pharmaceutical company headquartered in Cambridge, United Kingdom. It operates in various regions globally, including North America, Europe, and Asia. The company has a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products.
AstraZeneca has several prominent subsidiaries, including MedImmune LLC, a biologics research and development company, and Alexion Pharmaceuticals, Inc., a biopharmaceutical company specializing in rare diseases.
The company has a significant employee count, with thousands of employees worldwide. Its top operational locations include the United States, the United Kingdom, Sweden, and China, among others.
